Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quadrivalent influenza split-virion vaccine in 6–35 month-old children
CTR20170983Phase 3Completed
- Sponsor
- Changchun Institute of Biological Products Co., Ltd.
- Start
- Aug 2017
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of influenza vaccine (split virion, inactivated, quadrivalent) in influenza, sponsored by Changchun Institute of Biological Products Co., Ltd.. Started Aug 2017; status: completed.
02
Drugs
influenza vaccine (split virion, inactivated, quadrivalent)
03
Conditions
influenza
Beyond the preview
Go deeper on CTR20170983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170983.